Determination of stromal signatures in breast carcinoma

PLoS Biology

Volumn 3, Issue 6, 2005, Pages 1101-1110

  West, Robert B ^a   Nuyten, Dimitry S A ^b   Subramanian, Subbaya ^a   Nielsen, Torsten O ^c   Corless, Christopher L ^d   Rubin, Brian P ^e   Montgomery, Kelli ^a   Zhu, Shirley ^a   Patel, Rajiv ^f   Hernandez Boussard, Tina ^g   Goldblum, John R ^h   Brown, Patrick O ^g   Van De Vijver, Marc ^b   Van De Rijn, Matt ^a  

^a STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b NETHERLANDS CANCER INSTITUTE   (Netherlands)

^c VANCOUVER GENERAL HOSPITAL   (Canada)

^d OREGON HEALTH AND SCIENCE UNIVERSITY   (United States)

^e UNIVERSITY OF WASHINGTON MEDICAL CENTER   (United States)

^f EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

^g STANFORD UNIVERSITY MEDICAL CENTER   (United States)

^h LERNER RESEARCH INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

COMPLEMENTARY DNA; DNA;

ADULT; ARTICLE; BREAST CARCINOMA; BREAST TUMOR; CANCER SURVIVAL; CELL ACTIVATION; CELL POPULATION; CELL TYPE; COMPARATIVE STUDY; CONNECTIVE TISSUE CELL; CONTROLLED STUDY; DIFFERENTIAL DIAGNOSIS; DISEASE MARKER; DNA MICROARRAY; FEMALE; FIBROMA; GENE EXPRESSION PROFILING; GENETIC ANALYSIS; GENETICS; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; IN SITU HYBRIDIZATION; MULTIVARIATE ANALYSIS; PATHOLOGY; PROGNOSIS; SOFT TISSUE TUMOR; STATISTICAL SIGNIFICANCE; STROMA; STROMA CELL;

BREAST NEOPLASMS; DIAGNOSIS, DIFFERENTIAL; DNA, COMPLEMENTARY; DNA, NEOPLASM; FEMALE; FIBROMA; GENETICS; HUMANS; MULTIVARIATE ANALYSIS; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; PATHOLOGY; SOFT TISSUE NEOPLASMS; STROMAL CELLS;

EID: 22744445394     PISSN: 15449173     EISSN: 15457885     Source Type: Journal    
DOI: 10.1371/journal.pbio.0030187     Document Type: Article

References (25)

1. Kempson RL Fletcher CDM, Evans, HL, Hendrickson MR, Sibley RK (1998) Tumors of the soft tissues. Atlas of tumor pathology, series III. Rosai J, editor. Washington: AFIP. pp.1-21
2. England DM, Hochholzer L, McCarthy MJ (1989) Localized benign and malignant fibrous tumors of the pleura. A clinicopathologic review of 223 cases. Am J Surg Pathol 13: 640-658.
3. Fukunaga M, Naganuma H, Ushigome S, Endo Y, Ishikawa E (1996) Malignant solitary fibrous tumour of the peritoneum. Histopathology 28: 463-466.
4. Moran CA, Suster S, Koss MN (1992) The spectrum of histologic growth patterns in benign and malignant fibrous tumors of the pleura. Semin Diagn Pathol 9: 169-180.
5. van de Rijn M, Lombard CM, Rouse RV (1994) Expression of CD34 by solitary fibrous tumors of the pleura, mediastinum, and lung. Am J Surg Pathol 18: 814-820.
6. Chan JK (1997) Solitary fibrous tumour - everywhere, and a diagnosis in vogue. Histopathology 31: 568-576.
7. Fletcher CD, Dal Cin P, de Wever I, Mandahl N, Mertens F, et al. (1999) Correlation between clinicopathological features and karyotype in spindle cell sarcomas. A report of 130 cases from the CHAMP study group. Am J Pathol 154: 1841-1847.
8. Alman BA, Li C, Pajerski ME, Diaz-Cano S, Wolfe HJ (1997) Increased beta-catenin protein and somatic APC mutations in sporadic aggressive fibromatoses (desmoid tumors). Am J Pathol 151: 329-334.
9. Alman BA, Pajerski ME, Diaz-Cano S, Corboy K, Wolfe HJ (1997) Aggressive fibromatosis (desmoid tumor) is a monoclonal disorder. Diagn Mol Pathol 6: 98-101.
10. Middleton SB, Frayling IM, Phillips RK (2000) Desmoids in familial adenomatous polyposis are monoclonal proliferations. Br J Cancer 82: 827-832.
11. Linn SC, West RB, Pollack JR, Zhu S, Hernandez-Boussard T, et al. (2003) Gene expression patterns and gene copy number changes in dermatofi-brosarcoma protuberans. Am J Pathol 163: 2383-2395.
12. Nielsen TO, West RB, Linn SC, Alter O, Knowling MA, et al. (2002) Molecular characterisation of soft tissue tumours: a gene expression study. Lancet 359: 1301-1307.
13. Tusher VG, Tibshirani R, Chu G (2001) Significance analysis of microarrays applied to the ionizing radiation response. Proc Natl Acad Sci U S A 98: 5116-5121.
14. van de Rijn M, Rouse RV (1994) CD34: A review. Appl Immunohistochem 2: 71-80.
15. van de Vijver MJ, He YD, van't Veer LJ, Dai H, Hart AA, et al. (2002) A gene-expression signature as a predictor of survival in breast cancer. N Engl J Med 347: 1999-2009.
16. Lagace R, Schurch W, Seemayer TA (1980) Myofibroblasts in soft tissue sarcomas. Virchows Arch A Pathol Anat Histol 389: 1-11.
17. Perou CM, Sorlie T, Eisen MB, van de Rijn M, Jeffrey SS, et al. (2000) Molecular portraits of human breast tumours. Nature 406: 747-752.
18. Chang HY, Chi JT, Dudoit S, Bondre C, van de Rijn M, et al. (2002) Diversity, topographic differentiation, and positional memory in human fibroblasts. Proc Natl Acad Sci U S A 99: 12877-12882.
19. Chang HY, Sneddon JB, Alizadeh AA, Sood R, West RB, et al. (2004) Gene expression signature of fibroblast serum response predicts human cancer progression: Similarities between tumors and wounds. PLoS Biol 2: E7.
20. Iyer VR, Eisen MB, Ross DT, Schuler G, Moore T, et al. (1999) The transcriptional program in the response of human fibroblasts to serum. Science 283: 83-87.
21. Chang HY, Nuyten DS, Sneddon JB, Hastie T, Tibshirani R, et al. (2005) Robustness, scalability, and integration of a wound-response gene expression signature in predicting breast cancer survival. Proc Natl Acad Sci U S A 102: 3738-3743.
22. Allinen M, Beroukhim R, Cai L, Brennan C, Lahti-Domenici J, et al. (2004) Molecular characterization of the tumor microenvironment in breast cancer. Cancer Cell 6: 17-32.
23. West RB, Corless CL, Chen X, Rubin BP, Subramanian S, et al. (2004) The novel marker, DOG1, is expressed ubiquitously in gastrointestinal stromal tumors irrespective of KIT or PDGFRA mutation status. Am J Pathol 165: 107-113.
24. Liu CL, Prapong W, Natkunam Y, Alizadeh A, Montgomery K, et al. (2002) Software tools for high-throughput analysis and archiving of immunohistochemistry staining data obtained with tissue microarrays. Am J Pathol 161: 1557-1565.
25. Subramanian S, West RB, Corless CL, Ou W, Rubin BP, et al. (2004) Gastrointestinal stromal tumors (GISTs) with KIT and PDGFRA mutations have distinct gene expression profiles. Oncogene 23: 7780-7790.